🇺🇸 CIDOFOVIR ANHYDROUS in United States

4 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bone Marrow Failure — 1 report (25%)
  2. Haemolytic Anaemia — 1 report (25%)
  3. Neutropenia — 1 report (25%)
  4. Off Label Use — 1 report (25%)

Source database →

CIDOFOVIR ANHYDROUS in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CIDOFOVIR ANHYDROUS approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for CIDOFOVIR ANHYDROUS in United States?

Marketing authorisation holder not available in our data.